Microbio Co Ltd (TWO:4128) — Market Cap & Net Worth
Market Cap & Net Worth: Microbio Co Ltd (4128)
Microbio Co Ltd (TWO:4128) has a market capitalization of $287.22 Million (NT$9.12 Billion) as of May 4, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #15141 globally and #644 in its home market, demonstrating a -5.20% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Microbio Co Ltd's stock price NT$15.50 by its total outstanding shares 588170597 (588.17 Million). Analyse cash flow conversion of Microbio Co Ltd to see how efficiently the company converts income to cash.
Microbio Co Ltd Market Cap History: 2015 to 2026
Microbio Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $353.29 Million to $287.22 Million (-2.10% CAGR).
Microbio Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Microbio Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.35x
Microbio Co Ltd's market cap is 0.35 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $353.29 Million | $1.52 Billion | -$193.69 Million | 0.23x | N/A |
| 2016 | $307.30 Million | $1.52 Billion | -$267.81 Million | 0.20x | N/A |
| 2017 | $295.97 Million | $1.41 Billion | $543.03 Million | 0.21x | 0.55x |
| 2018 | $167.98 Million | $1.45 Billion | -$690.74 Million | 0.12x | N/A |
| 2019 | $189.31 Million | $1.47 Billion | -$264.60 Million | 0.13x | N/A |
| 2020 | $906.56 Million | $1.60 Billion | $519.84 Million | 0.57x | 1.74x |
| 2021 | $1.01 Billion | $1.78 Billion | -$233.16 Million | 0.57x | N/A |
| 2022 | $998.89 Million | $1.72 Billion | $152.42 Million | 0.58x | 6.55x |
| 2023 | $891.23 Million | $1.59 Billion | -$1.18 Billion | 0.56x | N/A |
| 2024 | $611.51 Million | $1.72 Billion | -$1.10 Billion | 0.35x | N/A |
Competitor Companies of 4128 by Market Capitalization
Companies near Microbio Co Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Microbio Co Ltd by market ranking:
- Nestlé S.A (F:NESM): Ranked #84 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #98 globally with a market cap of $203.05 Billion USD ( CHF160.61 Billion CHF).
- Danone SA (PA:BN): Ranked #527 globally with a market cap of $50.25 Billion USD ( €42.98 Billion EUR).
- Danone SA (F:BSND): Ranked #622 globally with a market cap of $42.57 Billion USD ( €36.41 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Nestlé S.A | F:NESM | $224.33 Billion | €85.60 |
| #98 | Nestle S.A. | SW:NESN | $203.05 Billion | CHF79.05 |
| #527 | Danone SA | PA:BN | $50.25 Billion | €66.74 |
| #622 | Danone SA | F:BSND | $42.57 Billion | €12.70 |
Microbio Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Microbio Co Ltd's market cap moved from $353.29 Million to $ 287.22 Million, with a yearly change of -2.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$287.22 Million | -16.22% |
| 2025 | NT$342.82 Million | -43.94% |
| 2024 | NT$611.51 Million | -31.39% |
| 2023 | NT$891.23 Million | -10.78% |
| 2022 | NT$998.89 Million | -1.55% |
| 2021 | NT$1.01 Billion | +11.92% |
| 2020 | NT$906.56 Million | +378.87% |
| 2019 | NT$189.31 Million | +12.70% |
| 2018 | NT$167.98 Million | -43.24% |
| 2017 | NT$295.97 Million | -3.69% |
| 2016 | NT$307.30 Million | -13.02% |
| 2015 | NT$353.29 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Microbio Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $287.22 Million USD |
| MoneyControl | $287.22 Million USD |
| MarketWatch | $287.22 Million USD |
| marketcap.company | $287.22 Million USD |
| Reuters | $287.22 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Microbio Co Ltd
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; pr… Read more